294 related articles for article (PubMed ID: 11031360)
1. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
2. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.
Valencia JC; Steagall WK; Zhang Y; Fetsch P; Abati A; Tsukada K; Billings E; Hearing VJ; Yu ZX; Pacheco-Rodriguez G; Moss J
Chest; 2015 Mar; 147(3):771-777. PubMed ID: 25411763
[TBL] [Abstract][Full Text] [Related]
3. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
6. Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.
Matsui K; Tatsuguchi A; Valencia J; Yu Zx; Bechtle J; Beasley MB; Avila N; Travis WD; Moss J; Ferrans VJ
Hum Pathol; 2000 Oct; 31(10):1242-8. PubMed ID: 11070117
[TBL] [Abstract][Full Text] [Related]
7. Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Matsumoto Y; Horiba K; Usuki J; Chu SC; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):327-36. PubMed ID: 10460750
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis].
Lü Y; Liao SL; Tang XN; Ye Q; Zhang L; Zhao HY
Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):84-7. PubMed ID: 15842802
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary lymphangioleiomyomatosis: report of one case].
Silva O R; Puelma C F; Retamal P V; Rojas Sm P; Cruzat C C; Reyes G C
Rev Med Chil; 2009 Nov; 137(11):1474-7. PubMed ID: 20098807
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
12. [Lung lymphangioleiomyomatosis (LAM)].
Cukić V; Lovre V; Beslić S; Bilalović N; Guska S
Med Arh; 2008; 62(3):180-2. PubMed ID: 18822952
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
14. Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Kumaki F; Takeda K; Yu ZX; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):187-91. PubMed ID: 12119231
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic analysis of pulmonary lymphangioleiomyomatosis].
Lu SH; Tan YS; Xu JF; Sujie A; Bai CX; Zhu XZ
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):664-9. PubMed ID: 20079279
[TBL] [Abstract][Full Text] [Related]
16. Lymphangioleiomyomatosis.
Taveira-DaSilva AM; Steagall WK; Moss J
Cancer Control; 2006 Oct; 13(4):276-85. PubMed ID: 17075565
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
18. Regional proliferation of HMB-45-positive clear cells of the lung with lymphangioleiomyomatosislike distribution, replacing the lobes with multiple cysts and a nodule.
Hironaka M; Fukayama M
Am J Surg Pathol; 1999 Oct; 23(10):1288-93. PubMed ID: 10524532
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex.
Schiavina M; Di Scioscio V; Contini P; Cavazza A; Fabiani A; Barberis M; Bini A; Altimari A; Cooke RM; Grigioni WF; D'Errico-Grigioni A
Am J Respir Crit Care Med; 2007 Jul; 176(1):96-8. PubMed ID: 17431222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
